Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival

Authors: Italiano, A. ^*, Toulmonde, M., Cioffi, A., Penel, N., Isambert, N., Bompas, E., Duffaud, F., Patrikidou, A., Lortal, B., Le Cesne, A., Blay, J.-Y., Maki, R.G., Schwartz, G.K., Antonescu, C.R., Singer, S., Coindre, J.-M., Bui, B.

Source: In Annals of Oncology June 2012 23(6):1601-1607

Données en vie réelle de l'utilisation du trastuzumab IV dans le carcinome mammaire métastatique HER2-positif.

Alternate Title: Real-life datas of intravenous trastuzumab use in metastatic breast cancer HER2-positive.

Authors: Genevée, T.¹ thomas.genevee@curie.fr, Lortal, B.²

Source: Oncologie (Tech Science Press). Jul2017, Vol. 19 Issue 7/8, p247-255. 9p.

1527TiP CONGRATS-combination of nivolumab plus relatlimab in patients with advanced or metastatic soft-tissue sarcoma: A proof-of-concept randomized phase II study

Authors: Spalato Ceruso, M., Albert, S., Italiano, A., Toulmonde, M., Cousin, S., Grellety, T., Blay, J-Y., Verret, B., Auzanneau, C., Valade, V., Poignie, L., Lortal, B., Kind, M., Le Loarer, F., Pulido, M.

Source: In Annals of Oncology September 2022 33 Supplement 7:S1243-S1243

1525TiP TORNADO: A randomized multicenter open-label phase II study evaluating retifanlimab in combination with neoadjuvant chemotherapy in patients with selected retroperitoneal sarcomas

Authors: Albert, S., Italiano, A., Toulmonde, M., Cousin, S., Bahleda, R., Brahmi, M., Watson, S., Auzanneau, C., Douiri, N., Poignie, L., Lortal, B., Le Loarer, F., Bellera, C.

Source: In Annals of Oncology September 2022 33 Supplement 7:S1242-S1243

781TiP AGADIR: A basket multicenter open-label phase II study evaluating the first in class TLR7/8 agonist BDB001 in combination with atezolizumab and stereotactic body radiation therapy in patients with advanced solid tumors

Authors: Italiano, A., Coutzac Bergouignan, C., Pasquier, D., Rochigneux, P., Sablin, M.P., Gomez-Roca, C.A., Ghiringhelli, F., Metges, J-P., Toulmonde, M., Cousin, S., Pernot, S., Auzanneau, C., Lortal, B., Kind, M., Sargos, P., Batard, S., Petit, A., Gillon, P., Albert, S., Pulido, M.

Source: In Annals of Oncology September 2022 33 Supplement 7:S898-S898

Preclinical study of an ex vivo gene therapy protocol for hepatocarcinoma.

Authors: Lortal, B¹, Gross, F.², Peron, J. M.³, Pénary, M.^1,4, Berg, D.¹, Hennebelle, I.⁵, Favre, G.^1,4, Couderc, B.^1,4,5 couderc.bettina@claudiusregaud.fr

Source: Cancer Gene Therapy. Apr2009, Vol. 16 Issue 4, p329-337. 9p. 1 Diagram, 4 Graphs.

Subject Terms: *LIVER cancer, *GENE therapy, *IMMUNOTHERAPY, *CIRRHOSIS of the liver, *FIBROBLASTS, *ANIMAL models in research, *CLINICAL trials

1842P Impact of medication reconciliation for patients enrolled in oncology early phases clinical trials: A drug-drug interactions retrospective study

Authors: Malifarge, L., Deppenweiler, M., Italiano, A., Lortal, B.

Source: In Annals of Oncology September 2020 31 Supplement 4:S1057-S1057

39. Dosimetric study of medical staff for selective internal radiation therapy using 90Y glass microsphere for the treatment of hepatic cancer

Authors: Ralite, F., Herit, S., Briceno, P., Kantor, G., Cazeau, A.L., Stein, Ph., Pottier, V., Lortal, B., Catena, V., Buy, X., Palussière, J., Caron, J.

Source: In Physica Medica December 2017 44 Supplement 1:44-44

1176P - IDO-1 and PD-L1 predict response to immunotherapy in advanced non small cell lung cancer: An NGS and multiplex IHC analysis

Authors: Leroy, L., Massé, J., Adam, J., Brouste, V., Signolle, N., Soubeyran, I., Velasco, V., Khalifa, E., Lortal, B., Italiano, A., Besse, B., Le Moulec, S.

Source: In Annals of Oncology September 2017 28 Supplement 5:v417-v417

Gestion du risque radioactif associé au décès d’un patient 12 heures après injection de Quadramet ®

Alternate Title: Management of radioactivity risk in patient's death 12 hours after Quadramet ® injection (English)

Authors: Lortal, B., Caron, J., Dejean, C., Bonichon, F., Houédé, N., Buj, S., Cazeau, A.-L.

Source: In Medecine Nucleaire 2009 33(12):754-757

2594 Safety and efficacy of Temsirolimus (Torisel®) as second line treatment for patients with recurrent bladder cancer

Authors: Houede, N., Roubaud, G., Mahammedi, H., Vedrine, L., Joly, F., Mourey, L., Pfister, C., Culine, S., Goberna, A., Lortal, B., Pulido, M., Pourquier, P., Bellera, C.

Source: In European Journal of Cancer September 2015 51 Supplement 3:S509-S509

Service pharmaceutique au patient dans les essais cliniques à l’institut Bergonié

Authors: Poignie, L., Genevee, T., Lortal, B., Bonnet, A., Joher, H., Lacomme, C., Pommier, M.

Source: In Le Pharmacien Hospitalier et Clinicien June 2014 49(2):e168-e168

'Metronomic' chemotherapy in advanced soft tissue sarcomas.

Authors: Italiano A, Toulmonde M, Lortal B, Stoeckle E, Garbay D, Kantor G, Kind M, Coindre JM, Bui B

Source: Cancer Chemotherapy & Pharmacology; 2010 May, Vol. 66 Issue 1, p197-202, 6p

R113: Analgésie par pompe intrathécale chez les patients atteints de cancer

Authors: Roudaut, M., Bouquey, C., Monnin, D., Apretna, E., Pommier, M., Lortal, B.

Source: In Bulletin du Cancer October 2010 97(4) Supplement:S59-S60

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

4. Clinical decision making utility of contrast-enhanced intraoperative ultrasound (CE-IOUS) during hepatectomy for colorectal liver metastases (CRLM): The Uliis phase 2 study.

Authors: Evrard, S.¹, Désolneux, G.¹, Isambert, M.¹, Mathoulin-Pélissier, S.², Bellera, C.², Hoppe, S.², Caroline, L.², Lortal, B.³, Derek, D.², Bellanguez, A.², Dupré, A.⁴, Rivoire, M.⁴, Catena, V.⁵, Palussière, J.⁵

Source: European Journal of Surgical Oncology. Sep2016, Vol. 42 Issue 9, pS67-S67. 1p.

Subject Terms: Liver metastasis, Contrast-enhanced ultrasound, Colon cancer diagnosis, Medical decision making, Hepatectomy, Clinical trials, Diagnosis, Therapeutics